Trials / Completed
CompletedNCT02035111
A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.
To Evaluate the Safety and the Efficacy of Tianshu Capsule Treating Migraine in a Randomized, Placebo-Controlled, Double-blind, Multicenter Study.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 947 (actual)
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and the efficacy of Tianshu capsule treating Migraine Headache.
Detailed description
Primary headache disorders,particularly migraine is globally prevalent. Many studies show the burdens they impose: pain, disability, reduced quality of life (QoL), marked impairment of participation in work and social activities, and heavy financial costs. The purpose of this study is to evaluate the safety and the efficacy of Tianshu capsule treating Migraine Headache. To provide a safe and effective treatment of Migraine Headache.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tianshu capsule | |
| DRUG | Sugar pill |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2015-04-01
- Completion
- 2015-11-01
- First posted
- 2014-01-14
- Last updated
- 2016-04-15
Locations
20 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02035111. Inclusion in this directory is not an endorsement.